The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers-Reference-Cited by-同舟云学术

The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers

Published:2021-11 Issue: Volume:157 Page:308-347
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Dyba Tadeusz,Randi Giorgia^ORCID,Bray Freddie,Martos Carmen,Giusti Francesco,Nicholson Nicholas,Gavin Anna,Flego Manuela,Neamtiu Luciana,Dimitrova Nadya,Negrão Carvalho Raquel^ORCID,Ferlay Jacques^ORCID,Bettio Manola

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference60 articles.

1. Eurostat. Causes of Death statistics (hlth_cd_asdr2). Available at: https://ec.europa.eu/eurostat/web/main/data/database. [Last accessed 1 April 2021].

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Canc,2019

3. United Nations, Population division. World Population Prospects, the 2017 revision. https://esa.un.org/unpd/wpp/. [Accessed March 2021].

4. The cost of cancer in Europe 2018;Hofmarcher;Eur J Canc,2020

5. Cancer in the European Community and its member states;Jensen;Eur J Canc,1990

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilisation of radiotherapy in lung cancer: A scoping narrative literature review with a focus on the introduction of evidence-based therapeutic approaches in Europe;Clinical and Translational Radiation Oncology;2024-03

2. Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast Tissue;Diagnostics;2024-02-04

3. Adherence to a healthy sleep pattern and risk of urologic cancers: A large prospective cohort study;Preventive Medicine;2024-02

4. The prognosis-based classification model in resectable pancreatic cancer;Surgical Oncology;2024-02

5. Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma;Archiv der Pharmazie;2024-01-31